Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic

Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic

Breast cancer is one of the most frequently diagnosed tumors and the second leading cause of cancer death in women worldwide. The use of nanosystems specifically targeted to tumor cells (active targeting) can be an excellent therapeutic tool to improve and optimize current chemotherapy for this type...

Full description

Bibliographic Details
Main Authors: Ana Isabel Fraguas-Sánchez, Irene Lozza, Ana Isabel Torres-Suárez
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
active targeting
albumin nanoparticles
antibody–drug conjugates
ephrin receptors
HER-2 receptors
liposomes
Online Access:https://www.mdpi.com/2072-6694/14/5/1198

Similar Items

Similar Items